Out of the 178 bills successfully passed by the Wyoming Legislature this year, a little more than 100 will go into effect on July 1. The new laws include a statewide ban on diversity, equity and ...

A newly reformed government cannabis commission in Virginia will meet next week to discuss the future of marijuana law in the commonwealth—a process widely expected to result in a revised proposal to ...

Governor Abbott vetoes Texas bill banning THC hemp products, citing legal issues, and calls for a special session to create a regulatory framework.

The US Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications.

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...

The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The update ...

The FDA approved a label update with a new titration schedule for donanemab (Kisunla), an anti-amyloid drug approved to treat ...

PRINCETON, N.J., June 27, 2025--U.S. FDA Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels ...

Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and showing good tolerability.

Successful trial data in a subset of hemophilia patients has set up Pfizer’s Hympavzi, which was approved eight months ago, for a label expansion ...

Teva has asked the Supreme Court to look at a judgment in a $235 million patent dispute with GSK that it claims could undermine the ability of generic drugmakers to bring new products to market ...